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Background
Sarcoidosis incidence is approximately 1:135,000
Americans. Cardiac involvement triggers multiple con-
duction disturbances, the most severe being complete
heart block and VT/VF. Non-caseating granulomas
have been found in the myocardium in up to 50% of
the cases of fatal sarcoidosis, and 67% of patients that
died from cardiac causes had myocardial involvement.
Late gadolinium enhancement cardiovascular MCMRRI
(LGE) has been shown to be more than twice as sensi-
tive for cardiac involvement per current consensus
Japanese Ministry of Health criteria and is widely held
but, as yet unproven, to be more sensitive than the
invasive RV endomyocardial biopsy.
Methods
A retrospective single center study was performed by
searching our cardiac MRI database for patients with pul-
monary sarcoidosis and possible cardiac involvement.
These patients’ electronic medical records were then eval-
uated for documented history of complete heart block,
ventricular arrhythmias and pacemaker and/or AICD
implantation. Using the keyword “cardiac sarcoidosis”, out
of more than 6,500 clinical cardiac MRIs performed from
2001-2012 at our institution, 118 patients were identified,
58 of whom had evidence of pulmonary sarcoidosis (25 by
biopsy, 12 by CT, 15 by MRI, and 6 by history).
Results
Out of >6500 pts, 118 were referree for sarcoid. LGE iden-
tified additional cardiac involvement in 21 patients (36%).
Five pts had documented VT while three pts had complete
heart block (CHB). All eight had an AICD/PM placed. In
the other 37 pts without cardiac involvement on LGE,
only 1 pt required AICD placed for a history of CHB
(p<0.05). LGE-defined cardiac involvement led to a signifi-
cant prediction for complete heart block and VT/VF
(p<0.001) as compared to more standard metrics.
Conclusions
Patients with non-invasive LGE-CMR identified cardiac
involvement have high potential to develop complete
heart block/ventricular arrhythmias. Propensity risks sug-
gest LGE may identify unstable electrical myocardium in a
subset of patients warranting prophylactic AICD/PM pla-
cement. LGE defined yearly risk estimate for cardiac sar-
coid (36%) is far greater than current post-implant AICD
firing rate in ischemic CMX (<1%) at one year.
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